The situation worsened with the Covid-19 pandemic and its double burden on cancer patients already immuno suppressed. Read MoreAmong women, breast cancer is the most common in Kenya, with more than 5,985 new cases and 2,553 deaths registered in 2018. Up to 30 percent of women diagnosed with and treated for early breast cancer will go on to develop metastatic breast cancer, which occurs when the cancer spreads beyond the breast. For breast cancer patients in Kenya, an innovative and much-needed new treatment option is now available to tens of thousands of women with HR+/HER2- metastatic breast cancer. As we all know, metastatic breast cancer (stage IV) places a heavy burden on patients and by extension their families, financially or otherwise.

Source: Standard Digital October 30, 2020 21:22 UTC